Leuprolide Acetate: Once-Yearly Subcutaneous Implant in Advanced Prostate Cancer

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.2, Iss.1, 2003-01, pp. : 57-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leuprorelin: Subcutaneous Depot Formulation (Eligard®) for Advanced Prostate Cancer

By Evans Hannah C. Wagstaff Antona J.

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 197-201

Adis International

Access to resources Recommend Favorite

A Phase II Study of Leuprolide in Advanced/Recurrent Endometrial Cancer

By Covens A. Thomas G. Shaw P. Ackerman I. Osborne R. Lukka H. Carey M. Franssen E. Roche K.

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 126-129

Elsevier

Access to resources Recommend Favorite

The UCSF advanced prostate cancer program

By Small E.J. Harris K.A. Frohlich M.W. Bok R.

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 5, 2001-09 ,pp. : 197-201

Elsevier

Access to resources Recommend Favorite

Leuprolide in the Treatment of Endometrial Cancer

By Markman M. Kennedy A. Webster K. Peterson G. Kulp B. Belinson J.

Gynecologic Oncology, Vol. 66, Iss. 3, 1997-09 ,pp. : 542-542

Elsevier

Access to resources Recommend Favorite

Leuprolide Acetate: A Viewpoint by Judd W. Moul

By Moul J.W.

American Journal of Cancer, Vol. 2, Iss. 1, 2003-01 ,pp. : 65-66

Adis International

Access to resources Recommend Favorite